Literature DB >> 35925405

MicroRNA-196a-5p overexpression in Wharton's jelly umbilical cord stem cells promotes their osteogenic differentiation and new bone formation in bone defects in the rat calvarium.

Yantong Wang1,2, Simin Zhang1, Haoqing Yang2, Yangyang Cao2, Dianqin Yu1, Yingchu Zhao1, Yu Cao3,4.   

Abstract

The peri-tooth root alveolar loss often does not have sufficient space for repair material transplantation and plasticity. Mesenchymal stem cell (MSC) sheets have an advantage in providing more extracellular matrix (ECM) and may prove to be a new therapeutic consideration for this bone defect repair. The identification of key regulators that stimulate MSCs' osteogenic potential and sheet-derived ECM deposition is the key to promoting its application. In this study, we found that inhibition or overexpression of miR-196a-5p led to a decline or enhancement, respectively, in the alkaline phosphatase (ALP) activity, mineralization, and the levels of osteogenic markers, Osteocalcin (OCN), Dentin Matrix Protein 1 (DMP1), Bone Sialoprotein (BSP), and Dentin Sialophosphoprotein (DSPP) of Wharton's jelly of umbilical cord stem cells (WJCMSCs) in vitro. Moreover, the 5,6-Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE) analysis revealed inhibition of the WJCMSCs' proliferative ability upon miR-196a-5p overexpression. Characterization of the sheet formation by picrosirius red and Masson staining indicated that miR-196a-5p overexpression significantly promoted the collagen content in whole WJCMSC sheet-derived ECM. Furthermore, micro-CT and histopathology results indicated that the miR-196a-5p-overexpressed WJCMSC sheets significantly promoted new bone regeneration and rat calvarial bone defect closure 12 weeks following transplantation. The mRNA microarray analysis of miR-196a-5p-overexpressed WJCMSCs revealed 959 differentially expressed genes (DEGs) (34 upregulated and 925 downregulated). Moreover, 241 genes targeted by miR-196a-5p were predicted by using miRNA function websites of which only 19 predicted genes were consistent with the microarray revealed DEGs. Hence, one unrevealed downregulated DEG Serpin Family B Member 2 (SERPINB2) was investigated. And the deletion of SERPINB2 enhanced the ALP activity and mineralization of WJCMSCs in vitro. In conclusion, our study found that miR-196a-5p, as a key regulator, could repress the proliferation tendency, while stimulating osteogenic ability and WJCMSC sheet-derived ECM deposition, thus promoting new bone formation and rat calvarial bone defect closure. Furthermore, SERPINB2 is a key downstream gene involved in the miR-196a-5p-promoted WJCMSC osteogenesis.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bone regeneration; Mesenchymal stem cells; Osteogenic differentiation; Wharton’s jelly umbilical cord stem cells; miR-196a-5p

Year:  2022        PMID: 35925405     DOI: 10.1007/s00441-022-03673-2

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   4.051


  43 in total

1.  Prospects for stem cell-based therapy.

Authors:  George Q Daley; David T Scadden
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

Review 2.  Mesenchymal stem cell sheets: a new cell-based strategy for bone repair and regeneration.

Authors:  Meikai Chen; Yifan Xu; Tan Zhang; Yuliang Ma; Junquan Liu; Bo Yuan; Xuerong Chen; Ping Zhou; Xiaofeng Zhao; Fei Pang; Wenqing Liang
Journal:  Biotechnol Lett       Date:  2019-01-24       Impact factor: 2.461

Review 3.  Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy.

Authors:  Dah-Ching Ding; Yu-Hsun Chang; Woei-Cherng Shyu; Shinn-Zong Lin
Journal:  Cell Transplant       Date:  2015-01-23       Impact factor: 4.064

Review 4.  Tissue engineering; strategies, tissues, and biomaterials.

Authors:  Behnaz Bakhshandeh; Payam Zarrintaj; Mohammad Omid Oftadeh; Farid Keramati; Hamideh Fouladiha; Salma Sohrabi-Jahromi; Zarrintaj Ziraksaz
Journal:  Biotechnol Genet Eng Rev       Date:  2018-01-31

5.  Epiregulin promotes osteogenic differentiation and inhibits neurogenic trans-differentiation of adipose-derived mesenchymal stem cells via MAPKs pathway.

Authors:  Yangyang Cao; Ruitang Shi; Haoqing Yang; Jianpeng Zhang; Lihua Ge; Runtao Gao; Zhipeng Fan
Journal:  Cell Biol Int       Date:  2020-01-26       Impact factor: 3.612

6.  A new semi-orthotopic bone defect model for cell and biomaterial testing in regenerative medicine.

Authors:  E Andrés Sastre; Y Nossin; I Jansen; N Kops; C Intini; J Witte-Bouma; B van Rietbergen; S Hofmann; Y Ridwan; J P Gleeson; F J O'Brien; E B Wolvius; G J V M van Osch; E Farrell
Journal:  Biomaterials       Date:  2021-10-18       Impact factor: 12.479

Review 7.  Prospect of mesenchymal stem cells in therapy of osteoporosis: A review.

Authors:  Leili Aghebati-Maleki; Sanam Dolati; Reza Zandi; Ali Fotouhi; Majid Ahmadi; Ali Aghebati; Mohammad Nouri; Seyed Kazem Shakouri; Mehdi Yousefi
Journal:  J Cell Physiol       Date:  2018-11-29       Impact factor: 6.384

Review 8.  Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells.

Authors:  John E Davies; John T Walker; Armand Keating
Journal:  Stem Cells Transl Med       Date:  2017-05-10       Impact factor: 6.940

9.  Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application.

Authors:  Raquel Cabrera-Pérez; Marta Monguió-Tortajada; Ana Gámez-Valero; Raquel Rojas-Márquez; Francesc Enric Borràs; Santiago Roura; Joaquim Vives
Journal:  Stem Cell Res Ther       Date:  2019-11-28       Impact factor: 6.832

Review 10.  Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis.

Authors:  Ahmed El-Badawy; Nagwa El-Badri
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.